Clinton Group’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-70,995
Closed -$3.15M 218
2018
Q2
$3.15M Buy
+70,995
New +$3.53M 0.49% 68
2018
Q1
Sell
-7,347
Closed -$368K 375
2017
Q4
$368K Sell
7,347
-74,407
-91% -$3.9M 0.03% 338
2017
Q3
$4.14M Sell
81,754
-18,743
-19% -$884K 0.45% 73
2017
Q2
$3.81M Buy
+100,497
New +$3.96M 0.39% 80
2016
Q4
Sell
-14,482
Closed -$232K 822
2016
Q3
$232K Buy
+14,482
New +$165K 0.01% 822

Other funds holding CC

Clinton Group's CC Position: Q3 2018 in Review

Clinton Group sold out of Chemours (CC) in Q3 2018, closing a stake of 70,995 shares — an estimated $3.15M sold.

Clinton Group first reported a position in CC in Q3 2016 and held it in 5 quarters. The position peaked at $4.14M in Q3 2017. 551 funds tracked by Wall St. Rank hold CC as of Q3 2018.

  • Clinton Group reported no remaining Chemours position as of Q3 2018 after selling out during the quarter.
  • Clinton Group sold 70,995 Chemours shares in Q3 2018, an estimated $3.15M.
  • Clinton Group first reported a position in Chemours in Q3 2016 and held it in 5 quarters.
  • Clinton Group's Chemours position peaked at $4.14M in Q3 2017.
  • 551 funds tracked by Wall St. Rank held Chemours as of Q3 2018.

Based on Clinton Group's 13F filing for Q3 2018, filed 10 Oct 2018.